Infectious Diseases

COVID health passes and credentials: what clinical labs need to know

COVID health passes and credentials: what clinical labs need to know

Clinical labs face a steep learning curve when integrating themselves into the new world of COVID-related “health passes”—the digital or paper certificates that allow individuals to demonstrate proof of a test result or vaccine record in order to cross borders, join events, enter facilities or otherwise move about the world with greater freedom than is […]

COVID health passes and credentials: what clinical labs need to know Read More »

In Canada, AI helps allocate COVID-19 tests accurately and fairly

In Canada, AI helps allocate COVID-19 tests accurately and fairly

At any time, managing a supply chain to ensure that clinical laboratories have ready access to the tests, reagents, and consumables they need to meet diagnostic demand can be a challenge — and that’s a challenge shared by healthcare systems, manufacturing companies, distributors, and even individual labs. But in a pandemic, that challenge becomes a

In Canada, AI helps allocate COVID-19 tests accurately and fairly Read More »

HCV screening in Egypt: key elements of a successful national screening programme

HCV screening in Egypt: key elements of a successful national screening programme

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Hepatitis C virus (HCV) infection is one of the world’s

HCV screening in Egypt: key elements of a successful national screening programme Read More »

How NGS tools have shaped the COVID-19 pandemic response

How next generation sequencing tools have shaped the COVID-19 pandemic response

Thanks to its availability and affordability, next-generation sequencing (NGS) has been an integral component of the scientific community’s response to the COVID-19 pandemic. Genomic data has enabled unprecedented pathogen surveillance and rapid development of diagnostic tests and vaccines based on the viral genome sequence. The very first look at the SARS-CoV-2 genome came from scientists

How NGS tools have shaped the COVID-19 pandemic response Read More »

For vaccination ‘passports’, the past offers a glimpse at the challenges ahead

For vaccination passports, the past offers a glimpse at the challenges ahead

Optimism about the development and rollout of vaccines for COVID-19 has spurred efforts to efficiently record and authenticate those who have been vaccinated. This has inspired new discussions of how to create a ‘vaccination passport’ that would allow the carrier to be able to travel between countries, return to work, go to school, attend events

For vaccination ‘passports’, the past offers a glimpse at the challenges ahead Read More »

Coagulation during COVID-19 and beyond: diagnostic challenges and opportunities

Addressing diagnostic challenges in coagulation during COVID-19 and beyond

The ongoing COVID-19 pandemic has had a profound worldwide impact on the Thrombosis and Hemostasis community. Nevertheless, the pace of COVID-19 coagulation-related research has continued to accelerate and has established the role of laboratory coagulation data for many purposes, including disease prognosis and outcome. Although the pathogenesis of the COVID-19-induced coagulopathy has not yet been

Coagulation during COVID-19 and beyond: diagnostic challenges and opportunities Read More »

China viewpoint: fourth-generation HIV testing brings big benefits

Screenshot of china viewpoint 4th generation HIV testing brings big benefits talk

Early detection of HIV infection can facilitate timely interventions that improve treatment outcomes and prevent further transmission. Fourth-generation HIV tests, which simultaneously detect both HIV antibodies and p24 antigens, allow healthcare practitioners to detect the virus with greater speed and accuracy than more traditional approaches. In China, clinical guidelines and laboratory processes are evolving to

China viewpoint: fourth-generation HIV testing brings big benefits Read More »

COVID-19 testing: Prof Aw Tar Choon on PCR, antigen and serology strategies

Aw Tar Choon webinar thumbnail

In a recent webinar hosted by Roche Diagnostics Asia Pacific, Professor Aw Tar Choon, Senior Consultant at the Department of Laboratory Medicine at Singapore’s Changi General Hospital, shares key updates on COVID-19 testing, including the growing array of rapid tests that provide quick return on results. Prof Aw explores the viral kinetics of SARS-CoV-2, which

COVID-19 testing: Prof Aw Tar Choon on PCR, antigen and serology strategies Read More »

Siloam Hospitals pursues digital transformation to take on COVID-19 pandemic

Siloam Hospitals pursues digital transformation to take on COVID-19 pandemic

Listen to Caroline Riady, Vice President Director of Siloam Hospitals in Indonesia, share the journey of how Siloam Hospitals stepped up to the challenge of COVID-19 to serve the people of Indonesia. As part of that journey, Siloam Hospitals launched various digital solutions for better patient education and engagement, placing the patient and community at

Siloam Hospitals pursues digital transformation to take on COVID-19 pandemic Read More »

COVID-19 in Taiwan: how clinical labs are driving successful containment

Chuwebinarimage

With only 500 confirmed cases and 7 deaths from COVID-19 as of mid-September, Taiwan is widely regarded as a success story in COVID-19 containment. Rapid mobilisation of clinical lab resources played an important role in the containment efforts, according to Dr Fang-Yeh Chu, Director in the Department of Clinical Pathology and QMC at Far Eastern

COVID-19 in Taiwan: how clinical labs are driving successful containment Read More »

Scroll to Top